Drugs@FDA document
RISPERDAL Review · NDA 020272 SUPPL-5
Drugs@FDA document · JANSSEN PHARMS · Jul 20, 2007
Key facts
| Drug name | RISPERDAL |
|---|---|
| Document type | Review |
| Application | NDA020272 |
| Submission | SUPPL-5 |
| Company | JANSSEN PHARMS |
| Document date | Jul 20, 2007 |
At a glance
- Manufacturing (CMC) Document categories
- 10–99 Documents for this application
- None USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: